---
figid: PMC6318317__41401_2018_60_Fig1_HTML
figtitle: Wnt signaling pathways and the intervention targets of Wnt pathway inhibitors
organisms:
- Mus musculus
- Rattus norvegicus
- Homo sapiens
- Drosophila melanogaster
- Danio rerio
- Lareunionomyces loeiensis
organisms_ner:
- Mus musculus
- Homo sapiens
- Rattus norvegicus
- Drosophila melanogaster
- Danio rerio
pmcid: PMC6318317
filename: 41401_2018_60_Fig1_HTML.jpg
figlink: /pmc/articles/PMC6318317/figure/Fig1/
number: F1
caption: Wnt signaling pathways and the intervention targets of Wnt pathway inhibitors.
  The secretion of Wnt proteins is dependent on palmitoylation by Porcupine. Frizzled
  and low-density lipoprotein receptor (LRP) proteins are membrane receptors for binding
  Wnt proteins. In the canonical Wnt pathway, Wnt binding leads to β-catenin nuclear
  translocation (after dissociation from a complex with Axin, glycogen synthase kinase
  3β (GSK3β), adenomatous polyposis coli (APC) and casein kinase 1α (CK1α)), causing
  its interaction with TCF/LEF transcription factors and gene transcription. In the
  Wnt/PCP pathway, Wnt binding results in RhoA/ROCK and Rac/Jnk/NFAT pathway transduction.
  In the Wnt/Ca2+pathway, Wnt binding leads to phospholipase C (PLC) activation and
  the accumulation of intracellular Ca2+, which then leads to the activation of calmodulin-dependent
  kinase II (CamKII), calcineurin and protein kinase C (PKC). UM206 targets the Frizzled
  receptor family; pyrvinium inhibits Axin degradation; ICG-001 inhibits the interaction
  between β-catenin and CBP; and WNT-974, CGX-1321 and GNF-6231 are porcupine inhibitors
papertitle: Wnt signaling pathways in myocardial infarction and the therapeutic effects
  of Wnt pathway inhibitors.
reftext: Wen-bin Fu, et al. Acta Pharmacol Sin. 2019 Jan;40(1):9-12.
year: '2019'
doi: .na.character
journal_title: .na.character
journal_nlm_ta: .na.character
publisher_name: .na.character
keywords: .na.character
automl_pathway: 0.9700639
figid_alias: PMC6318317__F1
figtype: Figure
redirect_from: /figures/PMC6318317__F1
ndex: 4ffe49a7-dec5-11ea-99da-0ac135e8bacf
seo: CreativeWork
schema-jsonld:
  '@context': https://schema.org/
  '@id': https://pfocr.wikipathways.org/figures/PMC6318317__41401_2018_60_Fig1_HTML.html
  '@type': Dataset
  description: Wnt signaling pathways and the intervention targets of Wnt pathway
    inhibitors. The secretion of Wnt proteins is dependent on palmitoylation by Porcupine.
    Frizzled and low-density lipoprotein receptor (LRP) proteins are membrane receptors
    for binding Wnt proteins. In the canonical Wnt pathway, Wnt binding leads to β-catenin
    nuclear translocation (after dissociation from a complex with Axin, glycogen synthase
    kinase 3β (GSK3β), adenomatous polyposis coli (APC) and casein kinase 1α (CK1α)),
    causing its interaction with TCF/LEF transcription factors and gene transcription.
    In the Wnt/PCP pathway, Wnt binding results in RhoA/ROCK and Rac/Jnk/NFAT pathway
    transduction. In the Wnt/Ca2+pathway, Wnt binding leads to phospholipase C (PLC)
    activation and the accumulation of intracellular Ca2+, which then leads to the
    activation of calmodulin-dependent kinase II (CamKII), calcineurin and protein
    kinase C (PKC). UM206 targets the Frizzled receptor family; pyrvinium inhibits
    Axin degradation; ICG-001 inhibits the interaction between β-catenin and CBP;
    and WNT-974, CGX-1321 and GNF-6231 are porcupine inhibitors
  license: CC0
  name: CreativeWork
  creator:
    '@type': Organization
    name: WikiPathways
  keywords:
  - Lrp6
  - Lrp5
  - Dvl1
  - Hspg2
  - Rhoa
  - Rho
  - Rhod
  - Ea2
  - Akt1
  - Camk2a
  - Camk2b
  - Apc
  - Gsk3b
  - Ctnnb1
  - Mapk8
  - Axin1
  - pl
  - Gm12892
  - Crebbp
  - Pag1
  - Cytip
  - WNT1
  - WNT2
  - WNT2B
  - WNT3
  - WNT3A
  - WNT4
  - WNT6
  - WNT7A
  - WNT7B
  - WNT8A
  - WNT8B
  - WNT9A
  - WNT9B
  - WNT10A
  - WNT10B
  - WNT11
  - WNT16
  - WNT5A
  - WNT5B
  - FZD1
  - FZD10
  - FZD2
  - FZD3
  - FZD4
  - FZD5
  - FZD6
  - FZD7
  - FZD8
  - FZD9
  - LRP6
  - LRP5
  - DVL1
  - DVL1P1
  - DVL2
  - DVL3
  - XIRP1
  - HSPG2
  - PLCE1
  - PLCZ1
  - PLCB1
  - PLCB2
  - PLCB3
  - PLCB4
  - PLCD1
  - PLCD3
  - PLCD4
  - PLCG1
  - PLCG2
  - RHOA
  - RHO
  - RHOD
  - RHOB
  - RHOC
  - AKT1
  - RAC1
  - RAC2
  - RAC3
  - RHOG
  - CAMK2G
  - APC
  - PROC
  - GSK3B
  - KRT10
  - CTNNB1
  - MAPK8
  - MAPK9
  - MAPK10
  - ROCK1
  - ROCK2
  - PRRT2
  - PRKCA
  - PRKCB
  - PRKCD
  - PRKCE
  - PRKCG
  - PRKCH
  - PRKCI
  - PRKCQ
  - PRKCZ
  - PRKD3
  - NFATC1
  - NFATC2
  - NFATC3
  - NFATC4
  - NFAT5
  - HNF4A
  - AXIN1
  - AXIN2
  - CSNK1A1
  - KRT1
  - CSNK1A1L
  - CREBBP
  - EIF4E
  - OPN1LW
  - PAG1
  - PCBP4
  - Wnt2
  - Camk2d
  - Prkcg
  - Nfat5
  - Csnk1a1
  - Wnt5
  - Wnt4
  - wg
  - fz
  - arr
  - dsh
  - norpA
  - sl
  - Plc21C
  - Rho1
  - rho
  - Bx
  - Lcp65Ab1
  - Rac1
  - Rac2
  - Akt
  - Mtl
  - CaMKII
  - Apc2
  - Axn
  - Fs(3)Apc
  - sgg
  - gskt
  - aurA
  - arm
  - bsk
  - Rok
  - inaC
  - Pkc98E
  - aPKC
  - Pkc53E
  - NFAT
  - pan
  - CkIalpha
  - gish
  - CBP
  - nej
  - eIF4E1
  - lrp6
  - lrp5
  - xirp1
  - rhoaa
  - rhoab
  - rnd2
  - apc
  - gsk3ba
  - ctnnb1
  - mapk8b
  - elk4
  - Ca2+
  - Pyrvinium
  - B-catenir B-catonin
  - Cancer
---
